Aesthetic Plastic Surgery最新文献

Background: Obesity is a growing global epidemic, with glucagon-like peptide-1 (GLP-1) receptor agonists emerging as effective pharmacological solutions for weight loss. However, these medications raise concerns in the context of aesthetic and reconstructive surgery due to their effects on wound healing, adipose tissue metabolism, and their potential impact on surgical outcomes.

Objective: To report two cases of delayed wound healing and fat necrosis in patients undergoing breast surgery while receiving GLP-1 receptor agonists for weight management.

Materials and methods: In our private clinical practice, two patients were observed. Both underwent breast surgeries (implant exchange with mastopexy and reduction mammoplasty) while using GLP-1 agonists (liraglutide). One patient continued therapy perioperatively, while the other discontinued seven days prior to surgery.

Results: Both patients experienced delayed wound healing. Wound dehiscence followed a characteristic progression involving fat necrosis and secondary healing. Despite standard surgical techniques and postoperative care, healing was prolonged in both cases.

Discussion: These findings highlight the potential impact of GLP-1-induced rapid weight loss on surgical outcomes. Current guidelines recommend therapy suspension to avoid anesthetic complications, but further studies are needed to evaluate the necessity of preoperative discontinuation in terms of surgical outcomes.

Conclusion: Our cases highlight the risk of delayed wound healing, fat necrosis, and tissue fragility in patients undergoing breast surgery while receiving GLP-1 receptor agonists. These complications have not been previously described in the literature, making this report particularly relevant as an alert for clinicians.

Level of evidence v: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors   www.springer.com/00266 .

Background: In most of the published plication techniques in face lift surgery, the vectors of plication are not entirely superiorly and vertically directed. The same applies with the deep plane, SMAS elevation techniques in the majority of which the vectors of traction are not superiorly vertically directed. The aging symptoms are mostly prominent at the anterior mobile face due to the gravity effect, and this is the area where attention should be focused to correct these symptoms following a face lift surgery.

Methods: We have evaluated the results of 58 patients who underwent the V plication face lift between January 2021 to January 2024 in terms of demographics, procedure, surgical technique, adjuvant treatments, final outcomes and complications.

Results: All 58 patients underwent primary face lift with the V plication for vertical superior traction and suspension of the facial tissues. The average age value was 64 years. Forty-six patients underwent concomitant upper and lower blepharoplasty, and 25 fat transfer of the upper periorbital region. There were one self-resolving neurapraxia of the right buccal branch of facial nerve and three minor self-absorbed localized blood collections.

Conclusion: The extensive V plication face lift of the anterior face together with the progressively less extensive plication of the lateral face due to the shape of plication addressed satisfactorily the prominent symptoms of gravity effect on the face with the action of the vertical superior suspension of the facial tissues and corrected the malar deflation by repositioning the downwards sliding malar fat pad.

Level of evidence v: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

The pursuit of aesthetically pleasing shoulder contours, particularly those characterised by a sharp, angular definition, has gained significant traction in Southeast Asia. Traditionally, neuromodulators have been used to achieve these results by inducing muscle atrophy, particularly in the trapezius muscles. However, this approach can carry potential risks, such as compromised muscle function and spinal instability. In response to these concerns, this article proposes a novel technique that combines the use of hyaluronic acid (HA) fillers with neuromodulators to achieve the desired shoulder contour. HA fillers, well established in facial aesthetics, offer the benefits of structural enhancement and long-term collagen stimulation. This combination technique aims to provide a more stable and natural-looking result by enhancing the underlying bone structure while selectively using neuromodulators to refine the shoulder profile. A clinical case study of a 32-year-old woman is presented, wherein 15cc of HA filler was injected into each shoulder to achieve a pronounced 90-degree contour, complemented by targeted neuromodulator injections in the deltoid muscles. The patient expressed high satisfaction with the outcome, noting the alignment with her aesthetic goals. This innovative approach has the potential to redefine shoulder contouring practices, offering patients a safer and more effective alternative to neuromodulators alone. Further research and clinical validation are necessary to fully establish the efficacy and safety of this technique.Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors  www.springer.com/00266 .

Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors  www.springer.com/00266 .

Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

The proliferation of unlicensed aesthetic medical (UAE) practices in China's plastic surgery industry highlights a pressing global concern, amplified by the growing "beauty economy." Social media platforms perpetuate unattainable beauty standards through edited images and curated pre- and post-operative photos, fueling demand for aesthetic treatments and exacerbating body dysmorphic disorder (BDD). Vulnerable individuals targeted by manipulative advertising often fall victim to unsafe UAE services. Generational differences further complicate this landscape: younger generations prioritize minimally invasive procedures for quick enhancements, while older individuals seek transformative surgeries, enabling UAE practitioners to exploit diverse preferences. The economic appeal of UAE services, particularly for middle- and lower-income consumers, underscores the need for democratized access to safe, reliable aesthetic treatments. Addressing these issues requires stricter regulation of digital advertising, public education on the psychological impacts of unrealistic beauty ideals, and subsidies or tiered pricing in licensed clinics. Broader multidisciplinary strategies, including collaborations with social media influencers and educators, are vital to promoting inclusive beauty standards and reducing demand for illicit procedures. By tackling the social, economic, and cultural drivers of UAE practices, policymakers can ensure a safer and more ethical aesthetic medicine industry, benefitting consumers and the broader market.Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors https://www.springer.com/00266 .